Investigation into the genetic origin of AIMAH led to the genotyping (both blood and tumor) of 33 patients with AIMAH, with detection of inactivating ARMC5 gene mutations in 55% (18/33) of tumors, as noted above [30]. Here, ARMC5 is linked to Cushing syndrome due to macronodular adrenal hyperplasia.